Source: Annual Congress 2004 - Advancements in pathobiology of respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. B. Snoeck-Stroband, T. S. Lapperre, M. M. E. Gosman, H. A. Thiadens, J. K. Sont, H. M. Boezen, H. A. M. Kerstjens, D. S. Postma, P. J. Sterk, the GLUCOLD Study Group (Leiden, Groningen, Leiden, Groningen, The Netherlands). Are symptoms of chronic bronchitis and sputum inflammatory cell counts related to the duration of smoking cessation in COPD?. Eur Respir J 2004; 24: Suppl. 48, 404

Member's Comments

No comment yet.

Related content which might interest you: Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005 Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation? Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Source: Eur Respir J 2004; 23: 464-476 Year: 2004 Duration of smoking cessation and bronchial inflammation in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006 frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema Source: Eur Respir J 2001; 17: 596-603 Year: 2001 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007 Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 The respiration status in smokers with chronic bronchitis during smoking cessation period Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002 The impact of smoking cessation on respiratory symptoms in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 391s Year: 2005 What are the consequences of chronic cough and expectoration for health status among patients with COPD? Source: Eur Respir J 2003; 22: Suppl. 45, 577s Year: 2003 Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 COPD disease progression and airway inflammation: uncoupled by smoking cessation Source: Eur Respir J 2005; 26: 764-766 Year: 2005 Effects of one year smoking cessation on inflammation in induced sputum of smokers with and without COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002